CHO Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '26 Apr 16, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	11,557	11,022	14,830	25,204	15,354	4,575
Market Cap Growth	-3.23%	-25.68%	-41.16%	64.15%	235.65%	3.48%
Enterprise Value	9,351	8,568	13,944	24,033	13,969	2,948
Last Close Price	54.00	51.50	69.30	137.00	83.50	24.90
PS Ratio	3600.18	3078.64	-	420067.12	4300.98	33148.76
PB Ratio	4.39	4.01	4.99	17.64	8.80	2.33
P/TBV Ratio	5.23	4.74	5.83	27.06	12.44	3.19
EV/Sales Ratio	-	2393.25	-	400545.33	3912.99	21363.14
Debt / Equity Ratio	0.01	0.01	-	0.01	0.02	0.02
Net Debt / Equity Ratio	-0.84	-0.85	-0.87	-0.72	-0.74	-0.76
Net Debt / EBITDA Ratio	8.61	9.83	10.40	3.18	6.99	5.27
Net Debt / FCF Ratio	8.88	10.49	8.88	3.99	6.59	5.55
Asset Turnover	0.00	0.00	-	0	0.00	0
Quick Ratio	21.33	20.41	24.57	6.19	9.89	10.22
Current Ratio	21.85	20.81	24.93	6.39	10.06	10.37
Return on Equity (ROE)	-8.37%	-7.41%	-13.90%	-21.33%	-11.11%	-14.05%
Return on Assets (ROA)	-5.82%	-5.22%	-7.17%	-12.55%	-6.52%	-8.47%
Return on Capital Employed (ROCE)	-10.20%	-9.00%	-9.00%	-24.50%	-12.00%	-15.50%
Earnings Yield	-1.99%	-1.93%	-2.06%	-1.34%	-1.34%	-6.49%
FCF Yield	-2.15%	-2.02%	-1.98%	-1.03%	-1.28%	-5.86%
Buyback Yield / Dilution	-3.72%	-11.86%	-4.00%	-0.04%	-0.12%	-0.36%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.